Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: Miguel M. de la O who wrote (285)	6/3/1998 4:27:00 PM
From: All Mtn Ski	Read Replies (2) \| Respond to of 548

Well, I am not too informed on NFLD's product, but it may not be that big a deal if they beat us to market. ALLP's product looks to be cheaper, easier to store, have a longer shelf life..ETC, so that it could place it ahead of NFLD's product in the market. Price will matter greatly IMHO, as HMO's and insurance co's look to bring down the cost of surgeries and medical care. Last I heard Oxygent is suppossed to be priced at same cost as a unit of blood. I believe Baxter's was to be about double that, but I don't know what NFLD will charge. Any insight? Tom